INTRODUCTION
The polyomavirus simian virus 40 (SV40) has been developed in recent years as a vector for gene transfer (1) (2) (3) (4) (5) (6) (7) (8) . SV40 virions prepared in a packaging cell line, which harbors the large T-antigen or other SV40 wild-type sequence, have been studied extensively (4) (5) (6) . However, SV40-based vectors can also be prepared in vitro without helper DNA, from the recombinant SV40 capsid protein VP1 (prepared in Sf9 insect cells) and supercoiled plasmid DNA (produced in bacteria) (1, 2) . Using the SV40 in vitro packaging system, we have demonstrated efficient delivery of multidrug-resistance transporter genes (such as ABCB1, ABCC1, and ABCG2) and the green fluorescent protein (GFP) gene into human lymphoblastoid, erythroleukemia, and stem cells (7, 8) . Previously, we showed that the in vitro-packaged vectors can encapsidate and efficiently deliver supercoiled DNA up to 17.7 kb in length (7, 8) . All types of SV40-based vectors (1) (2) (3) (4) (5) (6) (7) (8) have demonstrated highly efficient gene transfer, with almost 100% of transduced cells expressing the transferred gene.
Optimization of gene transfer using large-scale virion production, purification and concentration of the virions, and scaling up the transduction process, have been previously described only in those SV40 virions that harbor some of the SV40 wild-type sequence and that were prepared using a packaging cell line (see . In this type of SV40-based virion, these optimizations produce very efficient vectors with excellent potential to deliver genes in vitro as well as in vivo.
For in vitro-packaged SV40 pseudovirions, previous work has been done to optimize reaction conditions and volume as well to define optimal cell number (7, 8) . Here, we test four new protocols: (i) one for more efficient, scaled-up preparation of the in vitro packaging reaction; (ii) a second for transducing 10 times more cells than was previously possible; (iii) a third for concentrating pseudovirions; and (iv) a fourth for multiple transductions at 24-h intervals. Furthermore, we examine the efficiency and expression of delivery of the SV40 in vitro packaging system for many different cell types-nondividing as well as dividing cells-some of which no other delivery system has been able to transduce.
MATERIALS AND METHODS

Cell Lines and Cell Culture
.45 human lymphoblastoid cells with high levels of major histocompatibility complex class I (MHC I), and K562 human erythroleukemia cells were maintained in RPMI media (Invitrogen, Carlsbad, CA, USA (9) . Liver cells, human telomerase reverse transcriptase (hTERT)-immortalized cells, were kindly provided by Lyuba Varticovski, National Cancer Institute, NIH. All other media were supplementemd with 10% FBS (Hyclone, Logan, UT, USA), 5 mM L-glutamine, 50 mg/mL penicillin, and 50 mg/mL streptomycin (Quality Biological). All cell lines were kept at 37°C, in 5% CO 2 .
Transduction of Sf9 Cells with Baculovirus
A baculovirus construct containing the VP1 gene encoding SV40 capsid protein (1,2) was added to cells for 1 h with occasional mixing at a multiplicity of infection (MOI) of 10. Cells were then resuspended in fresh media. Four or five days later, the cells were harvested.
Preparation of Nuclear Extracts from Sf9 Cells
Extracts were prepared by shaking the nuclei, which were isolated with 10% Nonidet™P-40 (NP40) in a buffer containing 20 mM HEPES, pH 7.9 (Cellgro, Herndon, VA, USA), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA (all from Digene, Beltsville, MD, USA), 1 mM dithiothreitol (DTT; rpi, Mt. Prospect, IL, USA), and 1 mM phenylmethylsulfonylfluoride (PMSF; Fluka, Basel, Switzerland). DTT and PMSF were added before use (1,2).
Preparation of In Vitro Packaging Vectors
Packaged DNA in this study included the pEGFP-C1 construct (4.7 kb; BD Biosciences Clontech, Palo Alto, CA, USA), or the pHaMDR1 construct (8) . One hundred micrograms of nuclear extract from Sf9 cells, together with the 100 μg DNA construct in the presence of 5 mM ATP, and 8 mM MgCl 2 form viral-like particles during incubation at 37°C for 6 h in a 600-μL reaction volume (referred to hereafter as 1 reaction volume). The reaction tube was then incubated on ice for 1 h with 1 mM CaCl 2 (60 μL). The pEGFP-C1 construct was also packaged using scaled-up production methods. This involved mixing of all the components of 20 reactions in a 15-mL tube and separating the mixture into 20 individual microcentrifuge tubes before the 6-h incubation period.
Comparison of Transduction Methods
Cells were transduced in suspension with volumes of 660 μL in vitropackaged SV40 vectors in 10 tubes (10 4 cells each), in 60-and 100-mm culture dishes, and in T-25 flasks (10 5 cells in each). The dishes and flasks, which include a volume of 1 mL cells in medium and 660 μL of in vitro packaging reaction-a total volume of 1.66 mL, were then placed on a rotary shaker at 30 rpm for 2.5 h (at 37°C in 5% CO 2 ), after which 3.5 mL RPMI medium, supplemented with 10% FBS, 5 mM L-glutamine, 50 mg/mL penicillin, and 50 mg/mL streptomycin were added. Every in vitro packaging transduction experiment was done 3-6 times, and all the results were reproducible. Transduction was done in .45 and K562 cells using enhanced green fluorescent protein (EGFP) or a plasmid DNA (pHaMDR1) carrying the multidrug resistance gene (MDR1), as described previously (8) .
EGFP Gene Expression Detection
One to seven days posttransduction with EGFP-C1, 2 × 10 5 cells were washed and suspended in 200 μL phosphate-buffered saline (PBS; Invitrogen), 0.1% bovine serum albumin (BSA; Sigma) at 4°C, and analyzed by fluorescence-activated cell sorter (FACS; FL1) for EGFP as previously described (10) . The FL1 wavelength was used on the FACS machine, and the window placement was selected for each cell line. Cells only were set on the left side of the logarithmic scale, and any treated cells were measured using these settings. The same settings were kept in different experiments.
Rhodamine-123 Dye Exclusion Assay
Transduced cells (2 × 10 5 ) were incubated with 150 ng/mL rhodamine-123 for 20 min at 37°C and then washed and allowed to efflux the dye for 2 h at 37°C. As a control for this assay, we used untransduced cells. Immediately thereafter, the cells were analyzed by FACS using CellQuest™ software (BD Biosciences Immunocytometry Systems, San Jose, CA, USA).
Concentration of In Vitro Packaging Vectors
Using the microconcentrator filtering system (Centricon ® centrifugal filter devices for volumes up to 2 mL, YM-100 MW membranes; Millipore, Bedford, MA, USA), the in vitro-packaged vectors were concentrated from 1, 2, and 10 reaction volumes to 100 μL, 400 μL, and 1.5 mL, respectively. Once concentrated, they were used to transduce .45 cells. Both the concentrate and the filtrate were used to transduce cells.
Multiple Transductions of .45 Cells
In vitro-packaged EGFP was also used for multiple transductions of the .45 cell line. Twenty-four and fortyeight hours after the initial transduction, the same number of cells was retransduced with the packaged vectors. Aside from the multiple transductions, a sample of cells was tested for EGFP expression every 24 h and analyzed by FACS using CellQuest software.
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RESULTS
More Efficient Preparation of the In Vitro Packaging Reaction
Previous methods of producing SV40 in vitro packaging vectors required mixing all the components, such as the DNA, Mg 2+ , Ca 2+ , ATP, and VP1 nuclear extract, in individual microcentrifuge tubes before incubating them for 6 h in a 37°C water bath (2). Although this was an effective process, it was cumbersome and time-consuming. Therefore, we tried methods in which the different components were first mixed together in 15-mL tubes before separating the mixture into 5, 10, 15, or 20 individual microcentrifuge tubes. This new altered method of mixing in one tube before separating into separate ones not only led to the same or better expression than the original method (data not shown), but it was faster and increased the homogeneity of the final SV40 in vitro-packaged vectors. Incubation in the 37°C water bath of larger volumes in the 15-mL tubes was also tested, but did not result in efficient in vitro packaging (results not shown).
High Efficiency Transduction with SV40 Pseudovirions Using a ScaledUp Protocol
Our goal was to scale-up the transduction without loss of efficiency. The original SV40 in vitro-packaged EGFP transduction protocol for both .45 cells and K562 cells used a series of transduction experiments that used 10 tubes with 10 4 cells in each. In order to scaleup the transduction procedure, we compared 10 tubes with 10 4 cells in each, with 60-and 100-mm culture dishes and T-25 and T-75 flasks with 10 5 cells in each. The dishes and the flasks were placed in the incubator for 2.5 h on a rotary shaker (30 rpm), whereas the tubes were placed in the incubator and vigorously shaken every 15 min for a period of 2.5 h. After the transduction with the 10 tubes was completed, the tubes were pooled together into one flask for analysis 24 h to 4 days posttransduction. FACS analysis indicated that better expression was observed for 10 5 
Concentration of In Vitro-Packaged Reactions
The traditional size of an SV40 in vitro-packaged vector reaction is 660 μL, which includes 100 μg nuclear extract and 100 μg of supercoiled plasmid DNA. Previous studies in which the quantity of water during the pseudovirion preparation was lowered led to less expression (data not shown). Thus, we instead investigated the effects of concentrating the pseudovirions after the in vitro packaging reaction. After using the microconcentrator filtering system, both the concentrate and filtrate were set aside and used to transduce cells, with the concentrate yielding better expression than the filtrate and comparable expression in vitro to that of the original volume (660 μL), unconcentrated, as seen in Figure 2 . Using two original concentrated volumes of in vitro vectors revealed better expression than one, but not twice as much (data not shown). We conclude that concentration of the in vitro packaging system does not increase specific activity of transduction, but the same transduction activity can be achieved using smaller reaction volumes.
Transduction of a Variety of Cell Lines Using SV40 Vectors
Although the majority of the experiments discussed in this paper were conducted using the .45 human lymphoblastoid cell line, we also tested several cell lines with packaged EGFP to ascertain the variety of cell types that can be transduced with SV40 in vitro-packaged vectors. As shown in Figure 3 , we observed high expression in human GM08402 fibroblasts, WIF-B liver cells, and mouse keratinocytes. Ly3 lymphocytes, Ly10 lymphocytes, and HHT liver cells revealed slightly less expression, even though the transduction efficiency was very high as observed by the shift in the curves between the control cells and the transduced cells. Primary keratinocytes along with S1 cells did not show any expression. Except for the mouse S1 cells, all of the FACS plots shown here were obtained 2 days posttransduction of one reaction volume of in vitro-packaged EGFP to 10 5 cells. For mouse S1 cells, 0.25 reaction volume was used for 10 5 cells, and FACS analysis was performed 7 days posttransduction. In all cases, cells were split or plated 1 day prior to transduction.
We compared the transduction efficiency with another nonviral delivery system (lipofection) for these cell lines. Figure 4 compares two cell lines that are very difficult to transduce, the melanocytes and the keratinocytes. Efficiency is much higher in cells transduced by the SV40-packaged vectors than in the lipofectin-transfected cells, and expression levels on average are higher in the melanocytes.
Multiple Transductions to Increase Gene Expression
To determine if multiple transductions would increase the EGFP expression in the .45 cell line, we retransduced the same number of cells RESEARCH REPORT (10 5 ), 24, 48, and 72 h after the initial transduction with the packaged vectors. The remaining portion was used for FACS analysis. These steps were repeated until three transductions had occurred. As seen in Figure 5 , the primary transduction had less expression at 4 days than after the second, third, and fourth transductions at 72, 48, and 24 h, all of which had similar expression levels. FACS results of GFP expression revealed the median fluorescence intensity (arbitrary units) of control-transduced cells as 12, the first transduction as 30, the second transduction as 63, the third transduction as 58, and the fourth transduction as 51.
DISCUSSION
In this paper, we show the ability to transduce with high efficiency a wide variety of cell lines using SV40 pseudovirions, many of which are otherwise difficult to transduce using other delivery systems. We also present improved procedures for in vitro packaging of plasmid DNA and for transduction using the SV40 pseudovirion delivery system. These procedures include a scaled-up procedure for producing SV40 pseudovirions, a protocol to concentrate virion volume, and a method to transduce 10 times more cells than the original transduction protocol. Transducing different cell lines and analyzing EGFP expression by FACS showed a full shift in the curve from control cells to the transduced cells, indicating that all of the cells are expressing EGFP. This has been confirmed by confocal microscopy detection of EGFP in individual cells (data not shown). Thus, the cell lines all show high transduction efficiency except primary mouse keratinocytes and S1 cells, which did not have expression. This may be due to the low virion volume that was used for transduction of the S1 cells. Higher virion volumes than those used resulted in low viability of the S1 cells (data not shown). Comparisons with other nonviral delivery systems (such as lipofection) show that the SV40 pseudovirions are able to get into a wider variety of cell lines.
Introducing the EGFP gene on a daily basis led to greater expression than a single transduction of EGFP. These results could be applied in the future to animal studies where there is a need for transductions of packaged genes.
A new set of experiments led to more efficient production and transduction of the SV40 vectors. The scaled-up procedures for packaging allowed for homogenous mixtures of the virions, as well as faster overall production. The ability to concentrate the virion mixture to a smaller volume would facilitate injection in mouse tumors or tail-vein injections. Concentrating the virion mixture led to very similar EGFP expression compared to expression of cells transduced with unconcentrated EGFP. However, we detected a low level of expression in the filtrate, which might be explained by unpackaged DNA or small particles that pass through the filter membrane of the microconcentrator tubes. Unpackaged DNA in the regular procedure is eliminated using DNase I. Using two different cell lines and two different genes, we could demonstrate very efficient transduction of 10 times more cells as compared to the original protocol.
The new protocols examined here for SV40 pseudovirion production and transduction demonstrate the efficiency of this system to deliver genes to various cell lines and provide a much easier to use gene delivery system.
